Program 26 September 2023

IATP SYMPOSIUM (seperate registration required)

08.00-08.30 | REGISTRATION IATP SYMPOSIUM

08.30 - 08.40 | Welcome and Introduction | IATP Education Committee
08.40 - 09.30 | Toxicology Perspectives on MD Safety Assessment Requirements and Biocompatibility | Dr. Nicole Soucy, Ph.D.
09.30 - 10.20 | Focus on bone implant pathology: a workup, shortfalls and forecasts | Dr. Antoine Alves
10.20 - 10.50 | Extractables and leachable testing of medical devices | Dr. Flora Wegener, Ph.D.

10.50-11.20 | COFFEE BREAK

11.20 - 11.50 | Regulatory requirements and differences with various agencies and Regulatory differences in USA, Canada, Europe Including non-animal testing assays/approaches | Dr. Uta Bussmeyer PhD
11.50 - 12.25 | Panel Discussion

12.25 - 12.30 | Closing Remarks | IATP Education Committee

ESTP CONGRESS

12.30-13.30 | NETWORKING LUNCH & REGISTRATION ESTP CONGRESS

13.30-13.45 | Welcome | ESTP Chairman

13.45-14.45 | Keynote Lecture: Building the medicine toolbox: how did we get here and what is the Next Big Thing? | Richard Haworth

14.45-15.30 | The current state of nucleic acid therapeutics | Roy van der Meel

15.30-16.15  | COFFEE BREAK - POSTERS - EXHIBITION

16.15-16.45 | Pathology findings associated with systemic and IT delivered ASOs in preclinical safety studies | Kuldeep Singh 
16.45-17.15 | Findings with intrathecal dosing with ASO in NHP and rats | Annette Romeike 
17.15-18.00 | Regulatory aspects of preclinical oligonucleotide development | Helen-Marie Dunmore

18.00-19.15 | WELCOME RECEPTION